Huang, J., Yan, Z., Song, Y
A proteolysis-resistant MRI-visible nanoparticle formulation of GLP-1RA (nano-GLP-1RA) was engineered to target GLP-1Rexpressing cells within atherosclerotic lesions ( In ApoE/ mice, nano-GLP-1RA selectively accumulated in plaque-resident inflammatory and de-differentiated smooth muscle cells, consistent with GLP-1Rexpressing populations observed in human plaques ( Taken together, while imaging and omics technologies offer powerful tools to characterize vascular biology, their integration with GLP-1RA therapy for patient stratification remains an emerging concept that requires further clinical validation
By using data to identify health risk factors, inform targeted interventions and benefit offerings, employers can create successful, cost-effective programs to improve population health, which in turn leads to a more productive workforce
62 Different ligands lead to different interaction patterns with the receptor, generating various effects